.September 3, 2024 at 4:00:06 PM

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) operates in the eyecare and skincare market with products like Avenova and DERMAdoctor. NBY’s ROIC is -337.36% and WACC is 5.15%, resulting in a -65.53 ROIC/WACC ratio, indicating operational challenges or unprofitable investments. Guardion Health Sciences, Inc. (NASDAQ:GHSI) has a ROIC of -35.56% and WACC of 7.19%, leading to a -4.94 ROIC/WACC ratio, showing better efficiency. OpGen, Inc. (NASDAQ:OPGN) has a ROIC of -1341.30% and WACC of 12.98%, resulting in a -103.33 ROIC/WACC ratio, highlighting significant operational inefficiencies.